BioCardiAa (BCDA) PT Lowered to $19 at Brookline Capital Markets, Following Earnings
Tweet
Share
E-mailGet Alerts BCDA Hot Sheet
Price: $0.87 -3.33%
Rating Summary:
4 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Rating Summary:
4 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Join SI Premium – FREE
Brookline Capital Markets analyst Kumaraguru Raja lowered the price target on BioCardiAa (NASDAQ: BCDA) to $19.00 (from $22.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Upgrades Plains GP Holdings, L.P (PAGP) to Neutral
- Otsuka Holdings Co Ltd. (4578:JP) (OTSKY) PT Raised to JPY11,000 at Nomura/Instinet
- BorgWarner (BWA) PT Raised to $95 at Wolfe Research, 'Bullish Takeaways from CEO Meetings'
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
